EyePoint
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EyePoint and other ETFs, options, and stocks.About EYPT
EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands.
CEOJay S. Duker
CEOJay S. Duker
Employees165
Employees165
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded1987
Founded1987
Employees165
Employees165
EYPT Key Statistics
Market cap1.51B
Market cap1.51B
Price-Earnings ratio-6.11
Price-Earnings ratio-6.11
Dividend yield—
Dividend yield—
Average volume1.39M
Average volume1.39M
High today$18.34
High today$18.34
Low today$17.74
Low today$17.74
Open price$17.89
Open price$17.89
Volume630.02K
Volume630.02K
52 Week high$19.11
52 Week high$19.11
52 Week low$3.91
52 Week low$3.91
Stock Snapshot
The current EyePoint(EYPT) stock price is $17.91, with a market capitalization of 1.51B. The stock trades at a price-to-earnings (P/E) ratio of -6.11.
On 2026-01-01, EyePoint(EYPT) stock moved within a range of $17.74 to $18.34. With shares now at $17.91, the stock is trading +1.0% above its intraday low and -2.3% below the session's peak.
Trading volume for EyePoint(EYPT) stock has reached 630.02K, versus its average volume of 1.39M.
The stock's 52-week range extends from a low of $3.91 to a high of $19.11.
The stock's 52-week range extends from a low of $3.91 to a high of $19.11.
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own EYPT. This list is generated using Robinhood data, and it’s not a recommendation.